SARS-CoV-2 Spike Glycoprotein (Sotrovimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-SARS-CoV-2 Spike Glycoprotein (Sotrovimab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SARS-CoV-2 Spike Glycoprotein (Sotrovimab biosimilar) |
| Clone | Sotrovimab (VIR-7831/GSK4182136) |
| Host Species | Recombinant |
| Reactive Species | n/a |
| Isotype | Human IgG |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-SARS-CoV-2 Spike Glycoprotein Recombinant Antibody. Sotrovimab is an investigational monoclonal antibody therapy medication with activity against SARS-CoV-2. It is under development by GlaxoSmithKline and Vir Biotechnology, Inc. |
| Immunogen | n/a |
| Other Names | Anti-Spike Glycoprotein Recombinant Antibody, Research Grade Sotrovimab (VIR-7831/GSK4182136), Anti-SARS-CoV-2 Spike Glycoprotein Recombinant Antibody, VIR-7831, GSK4182136, Antibody Drug Analogues, Monoclonal Antibody, YR1642, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | n/a |
| Catalog # | YR1642 |
| Price | please inquire |
| Order / More Info | SARS-CoV-2 Spike Glycoprotein (Sotrovimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies